Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?
Gestational diabetes mellitus (GDM) is a complication that increasingly affects pregnant women. Due to the risk of adverse outcomes in the mother as well as in the fetus which is caused by GDM, appropriate diagnosis and treatment is very essential. Nevertheless, it is important to find new, effectiv...
Saved in:
Main Authors: | Angelika Sobota-Grzeszyk, Mariusz Kuźmicki, Jacek Szamatowicz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2019/3915253 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myoinositol: The Bridge (PONTI) to Reach a Healthy Pregnancy
by: Pietro Cavalli, et al.
Published: (2017-01-01) -
Role of Adipokines and Other Inflammatory Mediators in Gestational Diabetes Mellitus and Previous Gestational Diabetes Mellitus
by: Nikolaos Vrachnis, et al.
Published: (2012-01-01) -
Trends in the Diagnosis of Gestational Diabetes Mellitus
by: Surabhi Mishra, et al.
Published: (2016-01-01) -
Process Evaluations of Interventions for the Prevention of Type 2 Diabetes in Women With Gestational Diabetes Mellitus: Systematic Review
by: Iklil Iman Mohd Sa'id, et al.
Published: (2025-02-01) -
Gestational Diabetes Mellitus and Iron Deficiency Anemia
by: Neslihan Yerebasmaz, et al.
Published: (2015-12-01)